Atalanta Therapeutics
Latest round
- Series B
Last raised
- Jan 2025
Total raised
- $207M
Investors
- 11
About Atalanta Therapeutics
Atalanta Therapeutics, Inc.Founded in 2018 and headquartered in Boston, US, Atalanta Therapeutics specializes in RNA interference therapies.Atalanta Therapeutics specializes in developing innovative therapies for central nervous system (CNS) diseases, particularly Huntington’s disease. The company utilizes proprietary di-siRNA technology to silence disease-causing genes, aiming to halt disease progression.Atalanta Therapeutics operates with a combined B2B and direct-to-consumer model, generating revenue through collaborations with clinical trial sponsors and pharmaceutical partnerships. Their flagship product targets the HTT gene, with revenue structures involving upfront payments for research, milestone payments, and royalties from future sales.00 mn, Atalanta Therapeutics plans to advance its RNA interference therapies, specifically targeting KCNT1-related epilepsy and Huntington’s disease, through upcoming clinical trials and IND submissions. The company is focused on expanding its footprint in North America and Europe, aiming for broader market penetration by 2026.
Who invested in Atalanta Therapeutics
11 investors across 2 rounds
See all investors in Atalanta Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Atalanta Therapeutics
Who invested in Atalanta Therapeutics?
Atalanta Therapeutics has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Atalanta Therapeutics raised?
Atalanta Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Atalanta Therapeutics last raise money?
Atalanta Therapeutics's most recent round on record is a Series B, in Jan 2025.
What does Atalanta Therapeutics do?
Atalanta Therapeutics is a biotechnology company.
Where is Atalanta Therapeutics headquartered?
Atalanta Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Atalanta Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Atalanta Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Atalanta Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.